home / stock / ipsc / ipsc news

IPSC News and Press, Century Therapeutics Inc. From 04/23/24

Stock Information
Company Name: Century Therapeutics Inc.
Stock Symbol: IPSC
Market: NASDAQ
Website: centurytx.com
Menu
IPSC IPSC Quote IPSC Short IPSC News IPSC Articles IPSC Message Board
Get IPSC Alerts

News, Short Squeeze, Breakout and More Instantly...
IPSC - Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

PHILADELPHIA, April 23, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that members of the ...
IPSC - Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

Century is pursuing additional autoimmune disease regulatory filings for its iPSC derived iNK cell therapy, CNTY-101, beyond CALiPSO-1 trial in SLE, based on the potential of its differentiated profile Private placement of $60 million led by Bain Capital Life Sciences supports expansion...

IPSC - Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

PHILADELPHIA, April 08, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that preclinical data fr...

IPSC - Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event

2024-03-28 15:00:00 ET More on the markets Where This Market Is Going (Technical Analysis) SPY: 2 Opposing Forces Wall Street Lunch: Fed Not Spooked By Recent Inflation Overbought conditions flash across all market caps: Bespoke Investment Group Energ...
IPSC - Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the appointme...

IPSC - Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

PHILADELPHIA, March 19, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that members of the ...

IPSC - Century Therapeutics GAAP EPS of -$2.30, revenue of $2.2M

2024-03-14 11:45:29 ET More on Century Therapeutics Century Therapeutics: More Attention Doesn't Mean You Should Buy Into INK Cell Therapy Seeking Alpha’s Quant Rating on Century Therapeutics Historical earnings data for Century Therapeutics Financial ...
IPSC - Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

- Presented initial data from Phase 1 ELiPSE-1 Trial of CNTY-101 in relapsed/refractory B-cell lymphomas demonstrating a favorable tolerability profile, early clinical activity and indication that Allo-Evasion™ may support a multi-dosing regimen without the need for continued lymphodepleti...

IPSC - Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

PHILADELPHIA, March 05, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory diseases, today announced that preclinical data f...

IPSC - 3 Millionaire-Maker Under-$10 Stocks to Buy in February 2024

2024-02-22 13:10:18 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips You get what you pay for and that applies to under-$10 stocks. In many if not most cases, you’re dealing with speculative ideas that have little chance of swinging higher. Still, a handf...
Previous 10 Next 10